News Focus
News Focus
icon url

uksausage

03/15/17 11:30 AM

#103035 RE: legaltips #103032

but GSK is offering more why J&J? Why not McKesson they called yesterday....

this a real life Shark Tank with real mega-corporations bidding for a share of the whole business

like Shark Tank they will be offering different amounts for different slices and offering different services

Andy and the board has to review and assess, given they only got partial clearance that has reduced their offering for now, so do they wait another 6 months and just sign a simple distribution agreement to get in to all pharmacy shelves without the marketing etc?

The board has a responsibility to us the shareholders to do the best thing for us. That isn't take the first offer that comes along

I suspect we will know something by the end of the month, remember they just lost Ed and that will have impacted these meetings for sure.
icon url

srinsocal

03/15/17 11:41 AM

#103036 RE: legaltips #103032

AW has stated in the past that his preferred scenario is to have someone with the proper resources step in to handle the marketing. This would leave BIEL free to concentrate on Research and New Product Development. There are many new ActiPatch prototypes in the pipeline just waiting on funding to move forward.

I have to believe that this is still his goal as he negotiates with interested parties.